Amy Miller is the Executive Vice President for the Personalized Medicine Coalition (PMC) and joins us in our Special Report on LDTs Series. Though the PMC does not have a position on whether the FDA should regulate LDTs, Amy says that the stakes could not be higher.

“We see the future of personalized medicine is at stake. We urge the FDA to get this right the first time so that personalized medicine can continue to improve the quality of care that patients currently have access to,” she says at the outset of today’s interview.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

John LaMattina, Senior Partner, Pure Tech Ventures
Bio and Contact Info

Listen (6:27) Comparing drug approvals: 2014 with 1996

Listen (7:10) More rational drug development?

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

Paul Beresford, VP of Bus Dev, Biodesix
Bio and Contact Info

Listen (4:47) VeriStrat - a test for non-small cell lung cancer

Listen (4:39) What do you anticipate on the regulatory front?

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

Elaine Lyon, Former President, AMP; Medical Director of Molecular Genetics, ARUP Laboratories
Bio and Contact Info

Listen (4:37) What is at stake here?

Listen (6:16) Is your message being heard?

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

David Rimm, Professor of Pathology, Yale University School of Medicine
Bio and Contact Info

Listen (4:16) An unsexy science

Listen (5:36) A lack of certifications

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

Anna Barker, Co-Director, Complex Adaptive Systems Center, ASU
Bio and Contact Info

Listen (3:21) Andy's challenge

Listen (4:39) The year of immunotherapy

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

Surbhi Sarna, Founder, CEO, nVision Medical

Bio and Contact Info

Listen (4:43) Filling a void in female health innovation

Listen (4:31) Addressing the leading cause of infertility

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

Carolyn Compton, Professor of Pathology, ASU
Bio and Contact Info

Listen (4:54) A historic new consensus

Listen (6:33) CAP committed to enforcement

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

Geoffrey Ginsburg, Director, Duke Center for Applied Genomics and Precision Medicine
Bio and Contact Info

Listen (6:58) Genomic medicine occuring across the lifespan

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Guest:

Thomas Quertermous, Director of Research, Division of Cardiovascular Medicine, Stanford University
Bio and Contact Info

Listen (7:45) Close, but not quite there

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe